What Trommsdorff does

Trommsdorff GmbH & Co. KG is a German pharmaceutical manufacturer founded in 1790 in Erfurt and now headquartered in Alsdorf, Germany. The company develops, manufactures, and distributes prescription pharmaceuticals, over-the-counter medications, food supplements, complementary balanced diets, and medical devices. Its core branded products include Keltican forte (a peripheral nerve regeneration supplement featuring proprietary two-colored UMP-B pellets with vitamin B12, folic acid, UMP, and additional B vitamins), Tromcardin complex (electrolyte and vitamin B1 supplement for heart function), Zodin (omega-3 based blood lipid-lowering product with EPA and DHA from fish oil), and Ozym (high-dose pancreatic enzyme supplement for chronic pancreatic insufficiency). The company also offers contract manufacturing (Lohnfertigung) services to national and international pharmaceutical clients and holds proprietary mini-tablet technology for large active ingredient doses. All production is conducted in GMP-compliant facilities.

Trommsdorff distributes its products primarily through German pharmacies and supplements this channel with direct B2B sales for contract manufacturing. The company employs approximately 120 staff including temporary agency workers, and is a wholly-owned subsidiary of the publicly listed Dermapharm AG since January 1, 2018. Prior ownership was held by the Ferrer Group following integration in 1975. Revenue derives from a mix of branded consumer health products, prescription pharmaceuticals, and contract manufacturing services. The company targets patient segments in cardiology, neurology, respiratory medicine, and more recently urinary tract infections, with both healthcare professional and consumer marketing channels.

Name

Trommsdorff

Legal name

Trommsdorff GmbH & Co. KG

Website

https://trommsdorff.de

Company type

Private

Founded year

1790

Operating status

Operating

Headcount range

101–250 employees

Short description

Trommsdorff GmbH & Co. KG is a German pharmaceutical manufacturer, founded 1790 and based in Alsdorf, producing branded Rx/OTC drugs, food supplements, and medical devices, plus contract manufacturing services. A wholly-owned Dermapharm AG subsidiary serving cardiology, neurology, respiratory, and urology patients via pharmacy and B2B channels.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE)

akta.pro secondary industry

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

Keywords

• Pharmaceutical manufacturing
• Contract manufacturing services
• Food supplements production
• Cardiology neurology therapeutics
• Galenical development

Headquarters

HQ city

Alsdorf

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Products: Manufacturing and distribution of prescription and over-the-counter pharmaceutical products including cardiovascular, neurological, and respiratory medications.
2. Food Supplements: Production and sale of food supplements including vitamin combinations and nutritional products such as Tromcardin complex.
3. Medical Devices: Distribution of medical devices complementing the pharmaceutical product portfolio.
4. Supplementary Balanced Diets: Production and distribution of supplementary balanced diets for specific nutritional requirements.
5. Contract Manufacturing Services: Full-service contract manufacturing (Lohnfertigung) for national and international pharmaceutical customers.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Trommsdorff manufactures and distributes prescription pharmaceuticals, over-the-counter medications, food supplements, supplementary balanced diets, and medical devices from its GMP-compliant facility in Alsdorf, Germany. The company also provides full-service contract manufacturing (Lohnfertigung), galenical development, marketing, and distribution services to national and international pharmaceutical customers. Its core branded portfolio spans cardiovascular, neurological, respiratory, gastrointestinal, and urology therapies.

Product overview

Trommsdorff is a pharmaceutical company offering a portfolio of prescription and non-prescription products including branded medications, nutritional supplements, complementary balanced diets, and medical devices. The core non-prescription products are Keltican® forte (nerve regeneration supplement with UMP-B pellets), Tromcardin® complex (cardiovascular supplement with electrolytes and vitamin B1), Zodin® (omega-3 blood lipid lowering product), and Ozym (pancreatic enzyme supplement). Prescription products cover cardiovascular/cardiology, neurology, and respiratory therapies. The company also recently introduced an innovative product for urinary tract infections. As a Full-Service company, Trommsdorff offers comprehensive manufacturing, contract production (Lohnfertigung), marketing, and distribution services.

Differentiator

Problem solved

Functional benefit

Brands

• Keltican forte: Nerve regeneration supplement with vitamin B12, folic acid, uridine monophosphate (UMP), and vitamins B1, B3, B6 and D3 for peripheral nerve regeneration.
• Tromcardin complex
• Zodin
• Ozym

Products and services

• Keltican forte Nerve regeneration supplement (Nahrungsergänzungsmittel) featuring unique two-color UMP-B pellets with vitamin B12, folic acid, uridine monophosphate (UMP) plus vitamins B1, B3, B6 and D3, targeted at patients needing peripheral nerve regeneration support and nervous system function.
• Tromcardin complex Heart function food supplement (Nahrungsergänzungsmittel) combining electrolytes with vitamin B1, lactose-free, gluten-free, and vegan, intended for patients seeking cardiovascular and heart rhythm support.
• Zodin Non-prescription Arzneimittel containing high-dose EPA and DHA omega-3 fatty acids from fish oil for effective lowering of blood lipids in the therapy of lipid metabolism disorders.
• Ozym Prescription high-dose pancreatic enzyme product (Arzneimittel) indicated for chronic pancreatic insufficiency, taken as a complement to every meal.
• Prescription pharmaceuticals portfolio Portfolio of prescription-only medications spanning cardiovascular/cardiology, neurology, and respiratory indications in both children and adults.
• Urinary tract infection product Innovative non-prescription Arzneimittel recently introduced by Trommsdorff for the treatment of urinary tract infections.
• Medical devices Medical devices (Medizinprodukte) distributed by Trommsdorff as part of the broader product portfolio.
• Contract manufacturing (Lohnfertigung) Full-service contract manufacturing service offering galenical development, production, marketing, and sales support to national and international pharmaceutical customers from GMP-compliant facilities in Alsdorf, Germany.

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• Dermapharm AGcoreStrategic or Co-development Partner · 1 January 2018Trommsdorff became a company of the Dermapharm group on January 1, 2018. This ownership provides access to international markets, synergy effects within the Dermapharm network, and enhanced capabilities for innovation, growth, and efficiency. The partnership strengthens Trommsdorff's position to meet globalized market requirements.
• Laboratorios Ferrer S.L.coreStrategic or Co-development Partner · 1 January 1975Partnership with Laboratorios Ferrer S.L. in Barcelona was pivotal for Trommsdorff's development and led to full integration into the Ferrer Group in 1975. This collaboration shaped the company's product portfolio including cardiovascular, neurological, and respiratory therapies.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Strathmann GmbH & Co. KG: Sister company within the Dermapharm Gruppe producing branded Rx and OTC pharmaceuticals. Most directly comparable peer given shared ownership, similar German mid-market manufacturing footprint, and overlapping distribution through German pharmacies.
• Biologische Heilmittel Heel: German pharmaceutical manufacturer producing branded natural and conventional medicines with international reach. Comparable as a German pharma manufacturer with a similar branded product orientation and multi-therapeutic portfolio including neurology and pain indications.
• mibe Arzneimittel: Another Dermapharm Gruppe sister company manufacturing branded generics and OTC pharmaceuticals in Germany. Direct comparator given identical parent ownership, similar German manufacturing base, and parallel pharmacy-channel distribution model.
• Steigerwald Arzneimittelwerk: German pharmaceutical manufacturer of plant-based and branded Rx medicines. Comparable in its German mid-sized pharma profile, branded product orientation, and focus on specific therapeutic niches such as gastroenterology and neurology.
• Krewel Meuselbach: German pharmaceutical manufacturer of similar mid-market size focused on branded Rx products in respiratory and pain therapy. Comparable in its German mid-sized pharma manufacturing profile, branded product focus, and pharmacy-driven distribution.
• Hevert Arzneimittel: Independent German pharmaceutical company of comparable mid-market size producing branded Rx and OTC medicines as well as food supplements. Comparable in its broad-therapeutic branded product strategy and family-owned/independent operating history, mirroring Trommsdorff's full-service model.
• Hermes Arzneimittel: German pharmaceutical company with a similar mid-market scale, producing branded Rx and consumer health products. Comparable as a German mid-sized pharma manufacturer with multi-therapeutic product portfolio and pharmacy channel distribution.
• Salus Group: German family-owned manufacturer of branded food supplements, medicinal teas, and pharmaceutical products. Comparable in its German mid-sized manufacturing footprint and complementary positioning in food supplements and natural health products.
• Wörwag Pharma: German mid-sized pharmaceutical manufacturer with a similar profile of branded Rx and OTC products in cardiology, neurology, and metabolic therapy areas. Both companies operate as full-service German pharma manufacturers with multi-therapeutic portfolios distributed through pharmacy channels.

Broad incumbents

• Aenova Group: Larger German-headquartered CDMO and pharmaceutical manufacturer serving multiple international pharma customers. Relevant comparator for Trommsdorff's contract manufacturing (Lohnfertigung) business, though Aenova operates at meaningfully greater scale and breadth as a broad industry incumbent.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Trommsdorff